GlyNAC Dosage: What Human Trials Actually Used

GlyNAC does not have one standard dose. Human trials have used both fixed 1:1 glycine-to-NAC regimens and much larger weight-based protocols. Those study doses are useful for interpreting the research, but they should not be converted automatically into a personal supplement prescription.

GlyNAC doses used in human studies

Study	Total GlyNAC	Glycine	NAC	Duration
114-person dose-ranging RCT	2.4 g/day	1.2 g/day	1.2 g/day	2 weeks
114-person dose-ranging RCT	4.8 g/day	2.4 g/day	2.4 g/day	2 weeks
114-person dose-ranging RCT	7.2 g/day	3.6 g/day	3.6 g/day	2 weeks
16-week older-adult RCT	Weight-based	100 mg/kg/day	100 mg/kg/day	16 weeks

The clearest dose-ranging study: 2.4, 4.8 and 7.2 g/day

The most useful trial for answering “how much GlyNAC?” is the 114-person randomized dose-ranging study.

It tested three total GlyNAC doses in healthy older adults:

• 2.4 g/day total = 1.2 g glycine + 1.2 g NAC;
• 4.8 g/day total = 2.4 g glycine + 2.4 g NAC;
• 7.2 g/day total = 3.6 g glycine + 3.6 g NAC.

The ratio was 1:1, and treatment lasted only two weeks.

More was not automatically better

The study's overall circulating-glutathione endpoint did not improve significantly versus placebo across the full sample. Exploratory analyses suggested greater responsiveness among people starting with higher oxidative stress and lower glutathione status.

That is important because a dose-ranging trial is not a license to choose the largest tested number. The evidence does not establish 7.2 g/day total as a universal optimum.

The 16-week trial used a much higher weight-based dose

The small 16-week randomized trial in 24 older adults used 100 mg/kg/day of glycine and 100 mg/kg/day of NAC.

That means both components were dosed separately by body weight.

What does 100 mg/kg each mean in practice?

Body weight	Glycine	NAC	Total GlyNAC
60 kg	6 g/day	6 g/day	12 g/day
70 kg	7 g/day	7 g/day	14 g/day
80 kg	8 g/day	8 g/day	16 g/day
90 kg	9 g/day	9 g/day	18 g/day

These calculations reproduce the research protocol; they are not personal dosing recommendations.

Why the studies use such different doses

The GlyNAC literature is still early. Different research groups have asked different questions: short-term glutathione dose response, longer healthy-aging outcomes and pilot feasibility.

That is why there is not yet a universally accepted “maintenance dose,” “anti-aging dose” or “best dose.”

Does the 1:1 ratio matter?

The 114-person study used equal gram amounts of glycine and NAC. The 16-week weight-based trial also used equal milligrams per kilogram of each component.

That makes a 1:1 ratio the best represented combination in the current human literature. It does not prove that other ratios are ineffective or that 1:1 is optimal for every goal.

Is GlyNAC one supplement or two?

GlyNAC describes the combined use of glycine and NAC. It is not a new covalently bonded molecule.

A commercial product can package the two together, or a research protocol can provide them as separate ingredients. What matters scientifically is the actual amount of each component.

What about the pilot study?

The earlier 24-week pilot in eight older adults helped generate enthusiasm for GlyNAC, but its open-label design and tiny sample make it less useful for deciding an optimal dose than the later controlled studies.

How should you interpret a commercial GlyNAC label?

Check whether the label reports:

• grams of glycine;
• grams of NAC;
• the ratio between them;
• servings required to reach the stated daily amount.

A label that says “GlyNAC complex 1,000 mg” without disclosing each component makes it difficult to compare with the trials.

Safety and tolerability

Higher NAC exposure can increase gastrointestinal symptoms, and large glycine doses also add meaningful amino-acid intake. Trial participants were monitored.

For NAC-specific adverse effects and interactions, see NAC side effects and NAC drug interactions.

Bottom line

Published GlyNAC doses range from modest fixed combinations to very high weight-based protocols. The best current dose-ranging trial tested 2.4, 4.8 and 7.2 g/day total in a 1:1 ratio, while the small 16-week older-adult trial used 100 mg/kg/day of each component. The evidence does not yet establish one best dose for general use.